{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:22:49Z","timestamp":1779196969952,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.prro.2020.03.006","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T19:44:49Z","timestamp":1586893489000},"page":"e406-e414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Estimation of radiation-induced, organ-specific, secondary solid-tumor occurrence rates with total body irradiation and total marrow irradiation treatments"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3717-8473","authenticated-orcid":false,"given":"Chunhui","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey Y.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2020.03.006_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199501263320403","article-title":"Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia","volume":"332","author":"Zittoun","year":"1995","journal-title":"N Eng J Med"},{"key":"10.1016\/j.prro.2020.03.006_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.bmt.1700933","article-title":"Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"20","author":"Van Rhee","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.prro.2020.03.006_bib3","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/leu.2016.101","article-title":"Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party","volume":"30","author":"Sobh","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.prro.2020.03.006_bib4","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1182\/blood.V91.6.1833","article-title":"Malignancies after hematopoietic stem cell transplantation: Many questions, some answers","volume":"91","author":"Deeg","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.prro.2020.03.006_bib5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2005.02.7052","article-title":"Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation","volume":"24","author":"Leisenring","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.03.006_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.2011.08756.x","article-title":"Secondary cancers following allogeneic haematopoietic cell transplantation in adults","volume":"154","author":"Majhail","year":"2011","journal-title":"British J Haematol"},{"key":"10.1016\/j.prro.2020.03.006_bib7","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic cell transplantation","volume":"25","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2020.03.006_bib8","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.2018874115","article-title":"Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation","volume":"133","author":"Baker","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.prro.2020.03.006_bib9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/bmt.2012.258","article-title":"Surviving the cure: Long term followup of hematopoietic cell transplant recipients","volume":"48","author":"Majhail","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.prro.2020.03.006_bib10","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1118\/1.2044428","article-title":"Feasibility study of helical tomotherapy for total body or total marrow irradiation","volume":"32","author":"Hui","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbmt.2005.10.026","article-title":"Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: An alternative to standard total body irradiation","volume":"12","author":"Wong","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.prro.2020.03.006_bib12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijrobp.2006.10.047","article-title":"Image-guided total marrow and total lymphatic irradiation using helical tomotherapy","volume":"67","author":"Schultheiss","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/153303460600500508","article-title":"Linac-based intensity modulated total marrow irradiation (IM-TMI)","volume":"5","author":"Aydogan","year":"2006","journal-title":"Technol Canc Res Treat"},{"key":"10.1016\/j.prro.2020.03.006_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.radonc.2011.06.005","article-title":"Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation","volume":"102","author":"Han","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2020.03.006_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijrobp.2008.04.071","article-title":"Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation","volume":"73","author":"Wong","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ijrobp.2019.08.010","article-title":"Radiation related toxicities using organ sparing yotal marrow irradiation transplant conditioning regimens","volume":"105","author":"Shinde","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib17","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0360-3016(83)90412-1","article-title":"Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants","volume":"9","author":"Shank","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1667\/RR0763.1","article-title":"Solid cancer incidence in atomic bomb survivors: 1958-1998","volume":"168","author":"Preston","year":"2007","journal-title":"Radiat Res"},{"key":"10.1016\/j.prro.2020.03.006_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0360-3016(03)00073-7","article-title":"Radiation-induced second cancers: The impact of 3D-CRT and IMRT","volume":"56","author":"Hall","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib20","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1073\/pnas.0506648102","article-title":"Solid tumor risks after high doses of ionizing radiation","volume":"102","author":"Sachs","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prro.2020.03.006_bib21","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ijrobp.2004.12.040","article-title":"Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose","volume":"61","author":"Schneider","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1118\/1.3089792","article-title":"Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula","volume":"36","author":"Schneider","year":"2009","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib23","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ijrobp.2003.09.076","article-title":"Production and killing of second cancer precursor cells in radiation therapy","volume":"59","author":"Davis","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00411-007-0151-y","article-title":"Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy","volume":"47","author":"Schneider","year":"2008","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.prro.2020.03.006_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/02841860510029833","article-title":"The use of risk estimation models for the induction of secondary cancers following radiotherapy","volume":"44","author":"Dasu","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2020.03.006_bib26","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/blood.V77.8.1660.1660","article-title":"Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens","volume":"77","author":"Clift","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.prro.2020.03.006_bib27","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.V92.4.1455","article-title":"Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia","volume":"92","author":"Clift","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.prro.2020.03.006_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3857\/roj.2017.00290","article-title":"Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation","volume":"35","author":"Byun","year":"2017","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.prro.2020.03.006_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00066-007-1656-7","article-title":"20 years of experience in static intensity-modulated total-body irradiation and lung toxicity","volume":"183","author":"Schneider","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2020.03.006_bib30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0360-3016(01)02589-5","article-title":"Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation","volume":"52","author":"Della Volpe","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib31","series-title":"Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, National Research Council. Health risks from exposure to low levels of ionizing radiation: BEIR VII \u2013 Phase 2","year":"2006"},{"key":"10.1016\/j.prro.2020.03.006_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ijrobp.2010.11.041","article-title":"Verification of calculated skin doses in postmastectomy helical tomotherapy","volume":"81","author":"Ito","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib33","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1118\/1.2757000","article-title":"Helical tomotherapy superficial dose measurements","volume":"34","author":"Ramsey","year":"2007","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejmp.2012.04.004","article-title":"Dose to the skin in helical tomotherapy: Results of in\u00a0vivo measurements with radiochromic films","volume":"29","author":"Avanzo","year":"2013","journal-title":"Phys Med"},{"key":"10.1016\/j.prro.2020.03.006_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.radphyschem.2016.02.032","article-title":"Superficial dose evaluation of four dose calculation algorithms","volume":"137","author":"Cao","year":"2017","journal-title":"Radiat Phys Chem"},{"key":"10.1016\/j.prro.2020.03.006_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1120\/jacmp.v11i4.3351","article-title":"Verification of IMRT dose calculations using AAA and PBC algorithms in dose buildup regions","volume":"11","author":"Oinam","year":"2010","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2018.04.071","article-title":"Total body irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"101","author":"Wong","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2020.03.006_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0889-8588(18)30249-1","article-title":"Risk factors for the development of secondary malignancies after marrow transplantation","volume":"7","author":"Deeg","year":"1993","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.prro.2020.03.006_bib39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1200\/JCO.2003.05.108","article-title":"New malignancies after blood or marrow stem-cell transplantation in Children and adults: Incidence and risk factors","volume":"21","author":"Baker","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2020.03.006_bib40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/02841869409121767","article-title":"Secondary malignancies following cancer chemotherapy","volume":"33","author":"Boffetta","year":"1994","journal-title":"Acta Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850020300874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850020300874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:22:54Z","timestamp":1761819774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850020300874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1879850020300874"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2020.03.006","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimation of radiation-induced, organ-specific, secondary solid-tumor occurrence rates with total body irradiation and total marrow irradiation treatments","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2020.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}